Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection Free

Abstract

Four promoters, Cp, Wp, Fp and Qp, are known to participate in transcription of the Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) gene in EBV-infected cell lines. The promoters are used differentially during the different phases of infection and establishment of the stages of latency. This has raised questions about the regulation of the promoters and the molecular mechanisms underlying the switches between them. To obtain a measure of the activity of the different EBNA1 transcription units in EBV-transformed cell lines of different phenotypes, RNA probes were constructed that allowed the detection and relative quantification, by RNase protection analysis, of EBNA1 transcripts initiated at Fp and Qp and, in an indirect manner, Cp/Wp. RNase protection and PCR assays were performed with cytoplasmic RNA from B-lymphoid cell lines in latency stages I, II-III and III and after induction of the virus lytic cycle. The experiments demonstrated that, in addition to previously identified EBNA1 transcripts, cell lines of all latency types also contained different mRNAs that carried sequences from the EBNA1-encoding K exon. Induction of the virus lytic cycle resulted in low levels of an FpQ/U/K-spliced transcript. However, there was a large increase of FpQ- and FpQ/U-spliced transcripts with unknown 3′ sequences. Furthermore, a new transcript, initiated at an unidentified site 5′ of the BamHI f/K cleavage site and continuing through BamHI K into the EBNA1-encoding K exon without interruption, was produced in substantial amounts in the lytic cycle.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-2-457
1999-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/2/0800457a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-2-457&mimeType=html&fmt=ahah

References

  1. Altiok E., Minarovits J., Hu L. F., Contreras-Brodin B., Klein G., Ernberg I. 1992; Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein–Barr virus nuclear antigens 2–6. Proceedings of the National Academy of Sciences, USA 89:905–909
    [Google Scholar]
  2. Bodescot M., Perricaudet M., Farrell P. J. 1987; A promoter for the highly spliced EBNA family of RNAs of Epstein–Barr virus. Journal of Virology 61:3424–3430
    [Google Scholar]
  3. Favaloro J., Treisman R., Kamen R. 1980; Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. Methods in Enzymology 65:718–749
    [Google Scholar]
  4. Hudewentz J., Bornkamm G. W., zur Hausen H. 1980; Effect of the diterpene ester TPA on Epstein–Barr virus antigen- and DNA synthesis in producer and nonproducer cell lines. Virology 100:175–178
    [Google Scholar]
  5. Hudson G. S., Farrell P. J., Barrell B. G. 1985; Two related but differentially expressed potential membrane proteins encoded by the Eco RI Dhet region of Epstein–Barr virus B95-8. Journal of Virology 53:528–535
    [Google Scholar]
  6. Jansson A., Masucci M., Rymo L. 1992; Methylation of discrete sites within the enhancer region regulates the activity of the Epstein–Barr virus Bam HI W promoter in Burkitt lymphoma lines. Journal of Virology 66:62–69
    [Google Scholar]
  7. Kawasaki E. S. 1990; Amplification ofRNA. In PCR Protocols:A Guide to Methods and Applications pp 21–27 Edited by White T. J. San Diego: Academic Press;
    [Google Scholar]
  8. Kerr B. M., Lear A. L., Rowe M., Croom-Carter D., Young L. S., Rookes S. M., Gallimore P. H., Rickinson A. B. 1992; Three transcriptionally distinct forms of Epstein–Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology 187:189–201
    [Google Scholar]
  9. Kieff E. 1996; Epstein–Barr virus and its replication. In Fields Virology 3rd edn, pp 2343–2396 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  10. Lear A. L., Rowe M., Kurilla M. G., Lee S., Henderson S., Kieff E., Rickinson A. B. 1992; The Epstein–Barr virus (EBV) nuclear antigen 1 Bam HI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. Journal of Virology 66:7461–7468
    [Google Scholar]
  11. Masucci M. G., Contreras-Salazar B., Ragnar E., Falk K., Minarovits J., Ernberg I., Klein G. 1989; 5-Azacytidine up regulates the expression of Epstein–Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt’s lymphoma line Rael. Journal of Virology 63:3135–3141
    [Google Scholar]
  12. Mellinghoff I., Daibata M., Humphreys R. E., Mulder C., Takada K., Sairenji T. 1991; Early events in Epstein–Barr virus genome expression after activation: regulation by second messengers of B cell activation. Virology 185:922–928
    [Google Scholar]
  13. Nilsson T., Sjöblom A., Masucci M. G., Rymo L. 1993; Viral and cellular factors influence the activity of the Epstein–Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Virology 193:774–785
    [Google Scholar]
  14. Nonkwelo C., Daniel Henson E. B., Sample J. 1995; Characterization of the Epstein–Barr virus Fp promoter. Virology 206:183–195
    [Google Scholar]
  15. Nonkwelo C., Ruf I. K., Sample J. 1997; The Epstein–Barr virus EBNA-1 promoter Qp requires an initiator-like element. Journal of Virology 71:354–361
    [Google Scholar]
  16. Ricksten A., Olsson A., Andersson T., Rymo L. 1988; The 5′flanking region of the gene for the Epstein–Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells. Nucleic Acids Research 16:8391–8410
    [Google Scholar]
  17. Rowe M., Gregory C. 1989; Epstein–Barr virus and Burkitt’s lymphoma. Advances in Viral Oncology 8:237–259
    [Google Scholar]
  18. Rowe D. T., Rowe M., Evan G. I., Wallace L. E., Farrell P. J., Rickinson A. B. 1986; Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt’s lymphoma cells. EMBO Journal 5:2599–2607
    [Google Scholar]
  19. Rowe M., Lear A. L., Croom-Carter D., Davies A. H., Rickinson A. B. 1992; Three pathways of Epstein–Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Journal of Virology 66:122–131
    [Google Scholar]
  20. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning:A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  21. Sample J., Brooks L., Sample C., Young L., Rowe M., Gregory C., Rickinson A., Kieff E. 1991; Restricted Epstein–Barr virus protein expression in Burkitt lymphoma is due to a different Epstein–Barr nuclear antigen 1 transcriptional initiation site. Proceedings of the National Academy of Sciences, USA 88:6343–6347
    [Google Scholar]
  22. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, USA 74:5463–5467
    [Google Scholar]
  23. Schaefer B. C., Woisetschlaeger M., Strominger J. L., Speck S. H. 1991; Exclusive expression of Epstein–Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proceedings of the National Academy of Sciences, USA 88:6550–6554
    [Google Scholar]
  24. Schaefer B. C., Strominger J. L., Speck S. H. 1995a; TheEpstein–Barr virus Bam HI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt’s lymphoma cell lines. Journal of Virology 69:5039–5047
    [Google Scholar]
  25. Schaefer B. C., Strominger J. L., Speck S. H. 1995b; Redefining the Epsteinp-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proceedings of the National Academy of Sciences, USA 92:10565–10569
    [Google Scholar]
  26. Speck S. H., Strominger J. L. 1985; Analysis of the transcript encoding the latent Epstein–Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons. Proceedings of the National Academy of Sciences, USA 82:8305–8309
    [Google Scholar]
  27. Tsai C. N., Liu S. T., Chang Y. S. 1995; Identification of a novel promoter located within the Bam HI Q region of the Epstein–Barr virus genome for the EBNA 1 gene. DNA and Cell Biology 14:767–776
    [Google Scholar]
  28. Weigel R., Fischer D. K., Heston L., Miller G. 1985; Constitutive expression of Epstein–Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein–Barr virus replication. Journal of Virology 53:254–259
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-2-457
Loading
/content/journal/jgv/10.1099/0022-1317-80-2-457
Loading

Data & Media loading...

Most cited Most Cited RSS feed